Opus Genetics, Inc. (IRD) Tops Q1 EPS by 5c

Opus Genetics, Inc. (NASDAQ: IRD) reported Q1 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $4.37 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.

You May Also Be Interested In

• Manpower Inc. (MAN) PT Raised to $41 at UBS Ahead of Q2 Earnings
• Dave Inc (DAVE) PT Raised to $470 at UBS, Estimates Adjusted
• Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print